Thomas O’Halloran’s recent appointment as a Michigan State University Foundation Professor of Microbiology & Molecular Genetics and Chemistry completes a circle that began when he was a graduate student at Columbia University.
That’s when he became aware of pioneering work by MSU biophysicist Barnett Rosenberg, whose research in the 1970s led to the development of two transformative cancer-fighting drugs, cisplatin and carboplatin.
Michigan State University, Spectrum Health and Lansing-based company Niowave have teamed up to develop a new strategy to fight cancer
A potential new weapon against cancer is entering the first phase of clinical trials thanks to a collaboration between Spectrum Health, the Lansing-based company Niowave and Michigan State University.
Henry Ford Health System and Michigan State University, two of the state’s leading education, research and health care institutions, are partnering to make Michigan a national leader in providing access to exceptional health care for all residents, scientific discovery and education for providers, patients and families.
In a landmark partnership that will last for at least 30 years, both institutions are committed to aligning efforts across key departments and programs to achieve critical health care and educational goals, while addressing social issues that impact health outcomes for patients in Michigan and beyond.